V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20031658 | 20013510 | null | null | Adjuvant (A) | 2016-08-05 | 2016-08-24 | FEC + DOCETAXEL | null | null | 20111501 | FEC + DOCETAXEL |
| 20031659 | 20013510 | null | 58.7 | Adjuvant (A) | 2017-01-14 | 2017-02-10 | FEC + DOCETAXEL | N | N | 20111501 | FEC + DOCETAXEL |
| 20031660 | 20013511 | 1.34 | null | null | 2016-02-20 | 2016-03-11 | FEC + DOCETAXEL | N | N | 20111507 | FEC + DOCETAXEL |
| 20031661 | 20013511 | null | null | Adjuvant (A) | 2014-12-02 | 2014-12-17 | FEC 100 + DOCETAXEL | N | N | 20111507 | FEC + DOCETAXEL |
| 20031662 | 20013511 | 1.65 | 72.8 | Adjuvant (A) | 2017-10-26 | 2017-11-02 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | null | 20111507 | FEC + DOCETAXEL |
| 20031663 | 20013512 | 1.69 | 49.3 | Adjuvant (A) | null | 2016-07-23 | FEC 100 + DOCETAXEL | N | N | 20111525 | FEC + DOCETAXEL |
| 20031664 | 20013512 | 1.66 | 72.1 | Adjuvant (A) | 2013-08-13 | 2013-08-29 | FEC 100 + DOCETAXEL | N | N | 20111525 | FEC + DOCETAXEL |
| 20031665 | 20109444 | 1.53 | 57.4 | Adjuvant (A) | 2017-09-11 | 2017-09-13 | FEC 60 OR 75 + DOCETAXEL | 02 | N | 20111530 | FEC + DOCETAXEL |
| 20031666 | 20013513 | 1.7 | 67.95 | Adjuvant (A) | 2017-09-24 | 2017-10-02 | FEC 100 + DOCETAXEL | N | N | 20111533 | FEC + DOCETAXEL |
| 20031667 | 20013513 | 1.62 | 92 | Adjuvant (A) | 2013-06-17 | 2013-07-22 | FEC + DOCETAXEL | N | N | 20111533 | FEC + DOCETAXEL |
| 20031668 | 20013513 | null | 67.6 | Adjuvant (A) | 2018-04-08 | 2018-04-30 | FEC + DOCETAXEL | 02 | Y | 20111533 | FEC + DOCETAXEL |
| 20031669 | 20013514 | 1.53 | 65.4 | Adjuvant (A) | null | 2016-02-14 | FEC 100 + DOCETAXEL | null | N | 20111542 | FEC + DOCETAXEL |
| 20031670 | 20013515 | 1.51 | 67.8 | Adjuvant (A) | 2017-05-24 | 2017-06-08 | FEC + DOCETAXEL | N | N | 20111544 | FEC + DOCETAXEL |
| 20031671 | 20013515 | 1.78 | 65.2 | Adjuvant (A) | 2016-12-18 | 2016-12-20 | FEC + DOCETAXEL | 02 | N | 20111544 | FEC + DOCETAXEL |
| 20031672 | 20109446 | 1.69 | 65.6 | Adjuvant (A) | 2014-05-05 | 2014-05-15 | FEC + DOCETAXEL | 02 | N | 20111547 | FEC + DOCETAXEL |
| 20031673 | 20013516 | 1.61 | 74 | Adjuvant (A) | 2015-10-28 | 2015-11-04 | FEC + DOCETAXEL | 02 | N | 20111548 | FEC + DOCETAXEL |
| 20031674 | 20013516 | 1.63 | 67 | Neo-adjuvant (N) | 2016-06-05 | 2016-06-24 | FEC + DOCETAXEL | N | N | 20111548 | FEC + DOCETAXEL |
| 20031675 | 20013517 | 1.51 | 56.8 | Adjuvant (A) | 2015-07-28 | 2015-07-28 | FEC + DOCETAXEL | 02 | null | 20111562 | FEC + DOCETAXEL |
| 20031676 | 20013517 | 1.67 | 78.2 | null | null | 2014-03-01 | FEC + DOCETAXEL | N | N | 20111562 | FEC + DOCETAXEL |
| 20031677 | 20013518 | 1.68 | 57.1 | Curative (C) | 2016-09-25 | 2016-09-27 | FEC + DOCETAXEL | 2 | N | 20111565 | FEC + DOCETAXEL |
| 20031678 | 20013519 | 1.54 | 81 | Neo-adjuvant (N) | 2015-01-29 | 2015-02-09 | FEC + DOCETAXEL | 02 | Y | 20111569 | FEC + DOCETAXEL |
| 20031679 | 20013519 | 1.6 | null | Adjuvant (A) | null | 2013-09-19 | FEC 100 + DOCETAXEL | N | N | 20111569 | FEC + DOCETAXEL |
| 20031680 | 20013519 | 1.63 | null | Adjuvant (A) | 2016-08-10 | 2016-08-25 | FEC 100 + DOCETAXEL | N | N | 20111569 | FEC + DOCETAXEL |
| 20031681 | 20013520 | 1.73 | 67.6 | Curative (C) | 2014-05-05 | 2014-04-27 | FEC + DOCETAXEL | 02 | N | 20111575 | FEC + DOCETAXEL |
| 20031682 | 20013521 | null | 62 | Adjuvant (A) | 2015-02-07 | 2015-03-03 | FEC + DOCETAXEL | 1 | N | 20111577 | FEC + DOCETAXEL |
| 20031683 | 20013521 | 1.67 | 79 | Curative (C) | 2014-11-17 | 2014-12-02 | FEC 100 + DOCETAXEL | 2 | N | 20111577 | FEC + DOCETAXEL |
| 20031684 | 20013522 | 1.56 | 65.6 | Adjuvant (A) | 2017-11-18 | 2017-12-02 | FEC + DOCETAXEL | N | N | 20111581 | FEC + DOCETAXEL |
| 20031685 | 20013522 | null | 62.5 | Adjuvant (A) | 2017-08-10 | 2017-08-24 | FEC 100 + DOCETAXEL | N | N | 20111581 | FEC + DOCETAXEL |
| 20031686 | 20013522 | 1.65 | 84.4 | Adjuvant (A) | 2017-04-12 | 2017-04-19 | FEC + DOCETAXEL | 2 | N | 20111581 | FEC + DOCETAXEL |
| 20031687 | 20013522 | 1.65 | 74 | Adjuvant (A) | 2014-07-07 | 2014-07-07 | FEC 100 + DOCETAXEL | 2 | N | 20111581 | FEC + DOCETAXEL |
| 20031688 | 20013523 | 1.7 | 57.4 | Adjuvant (A) | 2016-12-11 | 2016-12-11 | FEC + DOCETAXEL | 02 | N | 20111609 | FEC + DOCETAXEL |
| 20031689 | 20013523 | 1.6 | 54 | Adjuvant (A) | 2018-01-14 | 2018-01-16 | FEC + DOCETAXEL | 02 | null | 20111609 | FEC + DOCETAXEL |
| 20031690 | 20013524 | 1.69 | 78 | Adjuvant (A) | 2016-05-26 | 2016-06-01 | FEC 100 + DOCETAXEL | 2 | N | 20111617 | FEC + DOCETAXEL |
| 20031691 | 20013525 | 1.69 | 68.8 | Neo-adjuvant (N) | 2014-10-06 | 2014-10-20 | FEC 100 + DOCETAXEL | 2 | null | 20111618 | FEC + DOCETAXEL |
| 20031692 | 20013526 | 1.68 | null | Adjuvant (A) | 2015-04-22 | 2015-05-18 | FEC + DOCETAXEL | 2 | N | 20111628 | FEC + DOCETAXEL |
| 20031693 | 20013526 | 1.53 | 82.4 | Neo-adjuvant (N) | 2017-07-03 | 2017-08-01 | FEC 100 + DOCETAXEL | 2 | N | 20111628 | FEC + DOCETAXEL |
| 20031694 | 20013526 | 1.62 | 64 | Adjuvant (A) | 2013-08-09 | 2013-09-20 | FEC 100 + DOCETAXEL | N | N | 20111628 | FEC + DOCETAXEL |
| 20031695 | 20013527 | 1.65 | 78 | Neo-adjuvant (N) | 2016-04-12 | 2016-05-02 | FEC 100 + DOCETAXEL | 02 | N | 20111634 | FEC + DOCETAXEL |
| 20031696 | 20013528 | 1.8 | 61 | Not known (9) | 2014-06-25 | 2014-07-03 | FEC + DOCETAXEL | N | N | 20111648 | FEC + DOCETAXEL |
| 20031697 | 20013528 | null | 68 | Adjuvant (A) | 2013-06-04 | 2013-06-05 | FEC + DOCETAXEL | 02 | N | 20111648 | FEC + DOCETAXEL |
| 20031698 | 20013528 | 1.68 | 71.6 | Neo-adjuvant (N) | null | 2017-04-03 | FEC 100 + DOCETAXEL | N | N | 20111648 | FEC + DOCETAXEL |
| 20031699 | 20013529 | 1.72 | 123.8 | Adjuvant (A) | 2016-07-11 | 2016-07-12 | FEC + DOCETAXEL | 02 | N | 20111658 | FEC + DOCETAXEL |
| 20031700 | 20013529 | 1.54 | 73 | Adjuvant (A) | 2015-01-13 | 2015-01-15 | FEC 100 + DOCETAXEL | 2 | N | 20111658 | FEC + DOCETAXEL |
| 20031701 | 20013530 | 1.78 | 63.4 | Adjuvant (A) | 2016-02-18 | 2016-02-20 | FEC + DOCETAXEL | 02 | null | 20111668 | FEC + DOCETAXEL |
| 20031702 | 20073255 | 1.61 | 117.3 | Adjuvant (A) | 2014-10-09 | 2014-10-16 | FEC + DOCETAXEL | N | N | 20111672 | FEC + DOCETAXEL |
| 20031703 | 20013531 | 1.64 | 105 | Curative (C) | 2015-11-26 | 2015-12-07 | FEC + DOCETAXEL | N | N | 20111673 | FEC + DOCETAXEL |
| 20031704 | 20013531 | 1.52 | 73.8 | Adjuvant (A) | 2015-09-26 | 2015-10-02 | FEC 100 + DOCETAXEL | N | null | 20111673 | FEC + DOCETAXEL |
| 20031705 | 20013531 | 1.57 | 87 | Adjuvant (A) | 2013-08-25 | 2013-09-07 | FEC + DOCETAXEL | 02 | N | 20111673 | FEC + DOCETAXEL |
| 20031706 | 20013531 | 1.77 | 62 | Neo-adjuvant (N) | 2016-07-13 | 2016-07-23 | FEC 100 + DOCETAXEL | 2 | N | 20111673 | FEC + DOCETAXEL |
| 20031707 | 20013532 | 1.58 | 71 | Curative (C) | 2013-07-21 | 2013-07-26 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20111688 | FEC + DOCETAXEL |